Ependymoma, a central nervous system tumor in the glioma family, is composed of neoplastic ependymal cells. Most ependymomas are WHO grade II, slow-growing tumors, but grades range from WHO grade I-III. Location and grade vary by patient age, with adult tumors typically spinal and grade I, and pediatric tumors mainly in the posterior fossa and grade II. Prognostic features include: age, location, grade and extent of resection with adult, spinal, grade I tumors having the best prognosis; and pediatric, intracranial, grade III tumors having the worst prognosis. Treatment is typically composed of surgical resection with or without radiotherapy, while chemotherapy has very little proven efficacy in ependymoma.
CITATION STYLE
Campen, C. J., & Fisher, P. G. (2012). Ependymoma: An overview. In Tumors of the Central Nervous System, Volume 8: Astrocytoma, Medulloblastoma, Retinoblastoma, Chordoma, Craniopharyngioma, Oligodendroglioma, and Ependymoma (pp. 269–277). Springer Netherlands. https://doi.org/10.1007/978-94-007-4213-0_26
Mendeley helps you to discover research relevant for your work.